Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G; kConFab; Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB. Rebbeck TR, et al. Among authors: rubinstein ws. Cancer Res. 2009 Jul 15;69(14):5801-10. doi: 10.1158/0008-5472.CAN-09-0625. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584272 Free PMC article.
Prophylactic mastectomy: obstacles and benefits.
Lynch HT, Lynch JF, Rubinstein WS. Lynch HT, et al. Among authors: rubinstein ws. J Natl Cancer Inst. 2001 Nov 7;93(21):1586-7. doi: 10.1093/jnci/93.21.1586. J Natl Cancer Inst. 2001. PMID: 11698554 No abstract available.
Cancer in Jews: introduction and overview.
Lynch HT, Rubinstein WS, Locker GY. Lynch HT, et al. Among authors: rubinstein ws. Fam Cancer. 2004;3(3-4):177-92. doi: 10.1007/s10689-004-9538-y. Fam Cancer. 2004. PMID: 15516840 Review.
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR. Friebel TM, et al. Among authors: rubinstein ws. Clin Breast Cancer. 2007 Dec;7(11):875-82. doi: 10.3816/CBC.2007.n.053. Clin Breast Cancer. 2007. PMID: 18269778
Stemming the tide of cancer for BRCA1/2 mutation carriers.
Lynch HT, Marcus JN, Rubinstein WS. Lynch HT, et al. Among authors: rubinstein ws. J Clin Oncol. 2008 Sep 10;26(26):4239-43. doi: 10.1200/JCO.2008.17.4201. J Clin Oncol. 2008. PMID: 18779610 Free PMC article. No abstract available.
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Neuhausen SL, et al. Among authors: rubinstein ws. Breast Cancer Res. 2009;11(5):R76. doi: 10.1186/bcr2414. Breast Cancer Res. 2009. PMID: 19843326 Free PMC article.
106 results